CIDRAP newsletters options
New research by scientists with the University of Mississippi Medical Center indicates that 30-day hospital readmission among patients who survived initial hospitalization with Staphylococcus aureus bloodstream infections is common and costly. The findings appeared yesterday in Clinical Infectious Diseases.
The 5 recent Omani cases involve women from North Batinah governorate who lived in the same household.
Researchers are trying to establish how many deaths can be attributed to antibiotic resistance.
Today the Centers for Disease Control and Prevention (CDC) announced that health workers are investigating potential exposures to a drug-resistant Brucella strain RB51 in 19 states. The strain comes from raw (unpasteurized) milk from Miller's Biodiversity Farm in Quarryville, Penn.
Over the weekend and through today the Democratic Republic of the Congo (DRC) health ministry reported 16 more lab-confirmed Ebola cases, 13 of them from Katwa, the outbreak's current hot spot. Also, in a Feb 9 update, health officials reported 7 more probable cases, all from Katwa involving people who became ill in November and December and died between November and January.
Transmission can be amplified in health settings when early cases aren't identified and isolated early and when proper infection prevention controls aren't in place.
Flu is widespread in 47 states, and the CDC reports 4 more pediatric flu deaths.
The new drug is a 'modernized' version of tetracycline, designed to address antibiotic resistance, but its clinical role isn't yet clear.
Today the Ministry of Health in the Democratic Republic of the Congo (DRC) confirmed two new cases of Ebola and three more deaths from the virus in the ongoing outbreak in North Kivu and Ituri provinces.
Outbreak totals now stand at 800 cases, including 502 deaths, and 178 suspected cases are still under investigation.
The accuracy of tuberculosis (TB) drug-susceptibility testing in high-burden countries was inadequate, and inaccurate test results led to inadequate treatment that contributed to higher mortality in patients with drug-resistant forms of the disease, an international team of researchers reported yesterday in The Lancet Infectious Diseases.
Partial protection from earlier dengue exposure in the favela population might explain Zika's quick decline there.
The Democratic Republic of Congo (DRC) health ministry today reported two more Ebola cases, one from Butembo and the other from Kyondo. In addition, 189 suspected cases are under investigation.
As Ebola cases rise in DRC, the virus continues to infect health workers in private and public health centers.
The push from drug developers and health groups asks Congress to take steps to prevent a public health crisis due to antibiotic resistance with few promising drugs in the pipeline.
Saudi Arabia's health ministry today reported three more MERS-CoV cases, two of them linked to ongoing outbreak activity in Wadi ad-Dawasir in the south-central part of the country.
Merck announced yesterday that the US Food and Drug Administration has accepted for priority review a New Drug Application (NDA) for the combination of relebactam and imipenem/cilastatin and a supplemental NDA for Zerbaxa (ceftolozane and tazobactam).
In a paper published yesterday in Emerging Infectious Diseases, a team of clinicians, infection control specialists, and pharmacists at a community hospital in Brooklyn described the management of patients with Candida auris bloodstream infections (fungemia).
Today the Democratic Republic of the Congo's (DRC's) health ministry reported three more cases and two new deaths in an ongoing Ebola outbreak. The outbreak now stands at 788 cases, including 486 deaths, and 191 suspected cases are still under investigation.
Also, experts call for the WHO to reconvene its Ebola emergency committee and consider declaring a public health emergency of international concern.
